Hims & Hers Acquires 503B Outsourcing Facility MedisourceRx

Gunderson Dettmer represented client Hims & Hers Health, a multi-specialty telehealth platform, in its acquisition of MedisourceRx, a 503B outsourcing facility in California. Hims & Hers provides personalized healthcare solutions by leveraging innovative pharmacy operations to offer tailored treatments such as custom dosages, allergen-free medications and sterile compounded products. This acquisition allows Hims & Hers to expand its sterile compounding offering and further reassure customers that they are getting access to an experience and products that meet standards for safety and quality.

In the announcement of the acquisition, Hims & Hers Health COO Melissa Baird said, “As we continue to expand the breadth of personalized solutions we offer, we’ve expanded our pharmacy operation capabilities through our acquisition of MedisourceRx, a 503B outsourcing facility in California. With expertise in sterile compounding, this 503B facility allows us to expand our sterile compounding offering and further reassure customers that they are getting access to an experience and products that meet our stringent standards for safety and quality.”

The Gunderson Dettmer team was led by public companies partner Alexa Belonick and M&A partner David Moore and included public companies associates Elena Vespoli and Daniel Reichert and corporate associates Oh Sung Kwon and Emma Anderson, strategic transactions partner Gina Marek and associate Cameron Jahansouz, executive compensation partner Sharon Hendricks and associate Sofia Rattes, data privacy partner Anna Westfelt and associate James Gately, tax/fund partner Jaime Narayan, employment and labor partner Natalie Pierce and associate Emily Borman.

Companies
Hims & Hers Health
MedisourceRx